Conclusion PTX treats the breast cancer of later period with the union chemotherapy scheme is effective, the poisonous side reaction can be tolerable.
2
结论：HEP方案对先前反复化疗失败的晚期乳腺癌有一定疗效，是可选择的治疗方案之一。
CONCLUSIONS: HEP regimen was modestly active in advanced breast cancer failed chemotherapy previously. It can be a choice for these patients.
3
目的评价CEF方案新辅助化疗治疗局部晚期乳腺癌的临床疗效和毒性反应。
Objective to evaluate the clinical efficacy and toxicity of CEF as the neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer (LABC).
点击反馈